Christina Paitazoglou

Luebeck, SH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart Failure.

Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart Failure.

Journal: The New England journal of medicine

Published: May 27, 2026

Left Atrial Appendage closure in patients with non-valvular atrial fibrillation and end stage chronic KIDNEY disease: Rationale and design of the prospective randomized LAA-KIDNEY trial.

Left Atrial Appendage closure in patients with non-valvular atrial fibrillation and end stage chronic KIDNEY disease: Rationale and design of the prospective randomized LAA-KIDNEY trial.

Journal: American heart journal

Published: May 04, 2026

Left atrial appendage closure in patients with non-valvular atrial fibrillation and end stage chronic KIDNEY disease: Rationale and design of the prospective randomized LAA-KIDNEY trial.

Left atrial appendage closure in patients with non-valvular atrial fibrillation and end stage chronic KIDNEY disease: Rationale and design of the prospective randomized LAA-KIDNEY trial.

Journal: American heart journal

Published: May 04, 2026

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure: Exploratory Analysis of the PRELIEVE study.

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure: Exploratory Analysis of the PRELIEVE study.

Journal: ESC heart failure

Published: March 18, 2026

Heart failure prevalence and incidence in Germany: National data on medical therapy and comorbidities.

Heart failure prevalence and incidence in Germany: National data on medical therapy and comorbidities.

Journal: International journal of cardiology

Published: March 01, 2026

Lp(a) in daily clinical routine: risk-factor for both cardiovascular events and heart-failure? A retrospective analysis of the Luebeck Lp(a) heart-failure (HF) registry in patients after myocardial infarction.

Lp(a) in daily clinical routine: risk-factor for both cardiovascular events and heart-failure? A retrospective analysis of the Luebeck Lp(a) heart-failure (HF) registry in patients after myocardial infarction.

Journal: Atherosclerosis plus

Published: April 28, 2025

Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial.

Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial.

Journal: JAMA

Published: March 30, 2025

Ischemic outcomes after left atrial appendage closure following intracerebral hemorrhage: a retrospective inverse probability weighting analysis from the HANSE-LAAC registry.

Ischemic outcomes after left atrial appendage closure following intracerebral hemorrhage: a retrospective inverse probability weighting analysis from the HANSE-LAAC registry.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: March 20, 2025

Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes.

Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes.

Journal: European journal of heart failure

Published: March 15, 2025

Implantable cardioverter-defibrillators in patients with left ventricular assist devices : Current controversies

Implantable cardioverter-defibrillators in patients with left ventricular assist devices : Current controversies

Journal: Herzschrittmachertherapie & Elektrophysiologie

Published: January 20, 2025

A heart failure network model to improve outcome and trans-sectoral guideline-directed medical treatment utilization.

A heart failure network model to improve outcome and trans-sectoral guideline-directed medical treatment utilization.

Journal: ESC heart failure

Published: January 16, 2025

Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials.

Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials.

Journal: European journal of heart failure

Published: December 22, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026